In theory, the observed positive association between IL‐33+ ECs and NYHA class may reflect, among other factors, increased ischemia in patients in whom the expression of IL‐33 in ECs is increased, causing microvascular cardiac disease (which is known to frequently occur in RA). This evidence concerns the gene IL33 and rheumatoid arthritis.